Skip to main content
Premium Trial:

Request an Annual Quote

Decode Nearly Doubles Revenues in Q2

NEW YORK (GenomeWeb News) – Decode Genetics reported after the close of the market on Wednesday that its second-quarter revenues nearly doubled to $15 million from $7.6 million year over year.
The Reykjavik, Iceland-based biopharmaceutical and molecular diagnostics firm noted in a statement that it also has $15.1 million in deferred revenue that will be recognized over future reporting periods.
Decode’s net loss increased 13.6 percent to $18.4 million, or $.30 per share, from $16.2 million, or $.27 per share. The quarter includes $1.2 million in non-operating expense tied to a revaluation of the firm’s non-current auction rate security investments. Decode also had taken charges in each of the previous two quarters related to the auction-rate securities.
The company’s R&D spending was cut 44.8 percent to $8 million from $14.5 million year over year, while its SG&A expenses edged up 4.4 percent to $7.1 million from $6.8 million.
Decode finished the quarter with $23.7 million in cash, cash equivalents, and current investments.
“As we ramp up our sales efforts in diagnostics and deCODEme, our discovery engine is providing us with a steady stream of intellectual property and content for new tests that leverage the same product development infrastructure,” Kari Stefansson, CEO of Decode, said in a statement.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.